Adding Immunotherapy to Chemotherapy for Endometrial Cancer
Cleveland Clinic Cancer Advances
by Cleveland Clinic Taussig Cancer Institute
3d ago
Roberto Vargas, MD, gynecologic oncologist at Cleveland Clinic, joins the Cancer Advances Podcast to discuss adding immunotherapy to chemotherapy for endometrial cancer. Listen as Dr. Vargas sheds light on recent studies demonstrating that adding checkpoint inhibitors to standard chemotherapy could notably lower the risk of cancer recurrence in patients with MMR-deficient or MSI-high tumors and the potential of genomic-based therapies for endometrial cancers ..read more
Visit website
Precision Healing: Stereotactic Radio Surgery for Adolescent Brain and Spine Tumors
Cleveland Clinic Cancer Advances
by Cleveland Clinic Taussig Cancer Institute
1w ago
Erin Murphy, MD, Director of Pediatric Radiation Oncology at Cleveland Clinic, joins the Cancer Advances Podcast to discuss stereotactic radio surgery (SRS) for adolescent and young adult brain and spine tumors. Listen as Dr. Murphy highlights the benefits of SRS for younger patients, including shorter treatment intervals, less impact on daily routine and recovery, and the ability to continue with school during treatment ..read more
Visit website
Peptide Therapy Innovations for Triple Negative Breast Cancer
Cleveland Clinic Cancer Advances
by Cleveland Clinic Taussig Cancer Institute
2w ago
The Cancer Advances podcast is joined by Ofer Reizes, PhD, the Laura J. Fogarty Endowed Chair for Uterine Cancer Research, and Justin Lathia, PhD, Melvin H. Burkhardt Endowed Chair for Neuro-Oncology Research, Scientific Director of the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, and the Vice Chair of the Department of Cardiovascular and Metabolic Sciences at Cleveland Clinic's Lerner Research Institute to discuss their research on peptide therapy as a targeted treatment for triple negative breast cancer. Listen as they explain their collaborative efforts to develop therapeutic ..read more
Visit website
Exploring the Microbiome in Young-Onset Colorectal Cancer
Cleveland Clinic Cancer Advances
by Cleveland Clinic Taussig Cancer Institute
1M ago
Young-onset colorectal cancer is becoming more common, and the microbiome could be playing a role in the increase of cases. Alok Khorana, MD, Director of the Gastrointestinal Malignancies Program at Cleveland Clinic Cancer Institute, joins the Cancer Advances Podcast to discuss this issue. Listen as Dr. Khorana highlights his research on the link between changes in the microbiome and the development and progression of colorectal cancer in younger patients. He also discusses the ongoing metabolomic analysis and investigations ..read more
Visit website
Advancing Organ Preservation in Rectal Cancer
Cleveland Clinic Cancer Advances
by Cleveland Clinic Taussig Cancer Institute
1M ago
The Cancer Advances podcast is joined by colorectal surgeons, I. Emre Gorgun, MD, Vice Chair of the Department of Colorectal Surgery, and Joshua Sommovilla, MD, Director of the Colon Cancer Tumor Board, to talk about organ preservation in rectal cancer treatment. Listen as they discuss the rising use of neoadjuvant therapy to shrink tumors before surgery, endoluminal procedures, and the importance of close surveillance and follow-ups for patients ..read more
Visit website
Trailblazing Urothelial Cancer Treatments: Enfortumab Vedotin & Pembrolizumab
Cleveland Clinic Cancer Advances
by Cleveland Clinic Taussig Cancer Institute
1M ago
Shilpa Gupta, MD, Director of the Genitourinary Oncology Program at Cleveland Clinic Cancer Institute, provides an overview of the clinical trial of enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer. Listen as Dr. Gupta talks about the exciting results of the trial, which showed that the combination therapy was effective for both cisplatin-eligible and cisplatin-ineligible patients. She also highlights the future studies that are being conducted to explore the use of the therapy in the neoadjuvant setting ..read more
Visit website
Beyond Chemotherapy: Advancements in ALL Treatment
Cleveland Clinic Cancer Advances
by Cleveland Clinic Taussig Cancer Institute
2M ago
Anjali Advani, MD, Director of the Inpatient Leukemia Unit at Cleveland Clinic, joins the Cancer Advances Podcast to talk about the innovations in acute lymphoblastic leukemia (ALL). While chemotherapy has traditionally been the go-to treatment, advancements like blinatumomab and CAR-T cell therapy are reshaping care. Listen as Dr. Advani discusses the challenges and considerations in choosing these therapies, CAR-T re-challenge potential, and the future directions in ALL treatments ..read more
Visit website
Exploring Novel Strategies for Chronic Lymphocytic Leukemia
Cleveland Clinic Cancer Advances
by Cleveland Clinic Taussig Cancer Institute
2M ago
Hematology oncologist, Allison Winter, MD, joins the Cancer Advances podcast to discuss the latest innovations in treating chronic lymphocytic leukemia (CLL). Listen as she explains how the treatment for CLL has evolved over the past decade, with a shift towards using novel therapies such as BTK inhibitors and venetoclax, as well as the concept of time-limited therapy. Dr. Winter also shares insights into ongoing clinical trials like the MAJIC trial, which compares different treatment combinations ..read more
Visit website
Enhancing Patient Care with Cancer Programming
Cleveland Clinic Cancer Advances
by Cleveland Clinic Taussig Cancer Institute
2M ago
Alison Ibsen, Senior Director for Cancer Programming, joins the Cancer Advances Podcast to talk about the role of cancer programming to enhance cancer patient care. Cancer programming brings together various experts involved in the treatment of a specific cancer to promote multidisciplinary care to help improve outcomes. Listen as Alison elaborates on the program development, its emphasis on creating effective care pathways, and the importance of collaboration across different locations and departments within Cleveland Clinic ..read more
Visit website
Advances in Stage 4 Colorectal Cancer Treatment
Cleveland Clinic Cancer Advances
by Cleveland Clinic Taussig Cancer Institute
3M ago
Michael Valente, DO, Program Director for the Colorectal Surgery Residency Program, and Director of the Peritoneal Surface Malignancy Program & Center for Metastatic Colorectal Cancer at Cleveland Clinic, joins the Cancer Advances Podcast to discuss advances in stage 4 colon cancer treatment. Listen as Dr. Valente highlights the significant improvements in outcomes for late stage colon cancer patients due to the recent advancements in surgery, chemotherapy, and immunotherapy. During the episode, he stresses the importance of early screening for colon cancer and the potential for personaliz ..read more
Visit website

Follow Cleveland Clinic Cancer Advances on FeedSpot

Continue with Google
Continue with Apple
OR